These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 5728720)
41. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. I. Patient data in the light of anamestic and subjective symptoms]. Olejak B; Szmatłoch E; Gregorczyk J; Cwajda H; Pieczul-Mróz J; Ansilewski K; Kornacewicz-Jach Z; Brzeźniak R Przegl Lek; 1983; 40(9):671-6. PubMed ID: 6665224 [No Abstract] [Full Text] [Related]
42. [General therapy of arteriosclerosis]. Siedek H Wien Klin Wochenschr; 1969 Jun; 81(25):464-6. PubMed ID: 5809151 [No Abstract] [Full Text] [Related]
43. Influence of ethyl-2 [chlorophenoxy]--2--methyl propionate [atromid--s] on liposoluble vitamins. Groh J; Dítĕ P; Vorácová J; Jelínek O Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1968; 11(3):Suppl:1-3. PubMed ID: 5254608 [No Abstract] [Full Text] [Related]
44. Atromid-S for the reduction of plasma lipids. Med Lett Drugs Ther; 1967 Jun; 9(12):45-7. PubMed ID: 6037633 [No Abstract] [Full Text] [Related]
45. [Studies on lipemia in elderly persons and the lipid lowering effect of a clofibrate derivate in 2 groups of test persons]. Rilliet B; Monnier J Praxis; 1969 Jun; 58(25):815-20. PubMed ID: 5819485 [No Abstract] [Full Text] [Related]
46. [Drug therapy of dyslipidemias]. Fonda M; Cattin L; Guarnieri G Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924 [No Abstract] [Full Text] [Related]
47. [Congenital defects of lipid metabolism. Effect of clofibrate on the level of blood lipids]. Sobra J Cas Lek Cesk; 1969 Nov; 108(48):1439-46. PubMed ID: 4901245 [No Abstract] [Full Text] [Related]
48. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. McCrindle BW; Ose L; Marais AD J Pediatr; 2003 Jul; 143(1):74-80. PubMed ID: 12915827 [TBL] [Abstract][Full Text] [Related]
49. Drug treatment of hyperlipidemia. Dujovne CA; Block JE Ration Drug Ther; 1984 Jun; 18(6):1-7. PubMed ID: 6531431 [No Abstract] [Full Text] [Related]
50. [Clinico-experimental studies on decreasing blood lipids in geriatrics]. Bracharz H; Laas H Med Monatsschr; 1966 Oct; 20(10):471-6. PubMed ID: 5978465 [No Abstract] [Full Text] [Related]
51. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders]. Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894 [No Abstract] [Full Text] [Related]
55. [Frameworks of recognition and classification of primary hyperlipidemia]. de Gennes JL Bull Acad Natl Med; 1994 Mar; 178(3):381-8; discussion 388-91. PubMed ID: 8076178 [TBL] [Abstract][Full Text] [Related]
56. Therapeutic use of lovastatin in the treatment of hypercholesterolemia. Illingworth DR Clin Ther; 1994; 16(1):2-26; discussion 1. PubMed ID: 8205598 [TBL] [Abstract][Full Text] [Related]
57. [Antilipidemic activity of ethyl-chloro-phenoxy-isobutyrate or clofibrate]. Barisone D; Gallo G; Accardo S Minerva Med; 1969 Jan; 60(6):174-80. PubMed ID: 5776766 [No Abstract] [Full Text] [Related]
58. The effect on serum tocopherol levels of drug-induced decrease in serum lipids. Weiss P; Bianchine JR Am J Med Sci; 1969 Oct; 258(4):275-81. PubMed ID: 5823464 [No Abstract] [Full Text] [Related]